Loading…
DIA Europe 2019 has ended
Back To Schedule
Thursday, February 7 • 09:15 - 10:15
#S0605: How to Facilitate Access to Advanced Therapy Medicinal Products in Europe

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Session

This session will focus on current experiences and challenges surrounding the market access of advanced therapy medicinal products. (ATMPs). The session will also highlight opportunities to secure access for patients to these innovative therapies, in particular for ATMPs addressing diseases with high unmet medical needs.

Chair

Maria Pascual, PharmD

Speaker

Can We Improve Access to ATMPs? The Results of ARM’s Multi-Stakeholder Study
Paolo Morgese, MSc

Practical Challenges for Access of ATMPs in Europe – An Industry Perspective
Etienne Jousseaume

Challenges in the Development of ATMPs in Europe – A Regulator Perspective
Ilona G. Reischl, PhD, MPharm


Speakers
EJ

Etienne Jousseaume

Head Market Access Cell and Gene Europe, Novartis
avatar for Paolo Morgese

Paolo Morgese

Director, EU Market Access and Member Relations, Alliance for Regenerative Medicine (ARM)
Paolo is a healthcare investment and market access professional with more than 15 years of experience in both assessing and supporting access to innovative healthcare technologies. Paolo’s interests and expertise are centered around healthcare technology value assessment and maximization... Read More →
MP

Maria Pascual

Chair of Advanced Therapies Working Group, EBE-EFPIA
Pharmacy degree from Granada University, PhD in Immunology from Spanish National Research Council, and Master degree in Regulatory Affairs from Barcelona Autonoma University. Worked with peptides and vaccines in autoimmune diseases in LUMC, The Netherlands and Mayo Clinic, US. Specialized... Read More →
MP

Maria Pascual

Chair of Advanced Therapies Working Group, EBE-EFPIA
Pharmacy degree from Granada University, PhD in Immunology from Spanish National Research Council, and Master degree in Regulatory Affairs from Barcelona Autonoma University. Worked with peptides and vaccines in autoimmune diseases in LUMC, The Netherlands and Mayo Clinic, US. Specialized... Read More →
avatar for Ilona Reischl

Ilona Reischl

Biologics Quality Assessor, Austrian Medicines and Medical Devices Agency (AGES MEA), Austria
Ilona Reischl joined the Austrian Agency in March 2006 and is currently an assessor within the clinical trials unit that is responsible for the evaluation of clinical trials with medicinal products and medical devices as well as GCP inspections. Her background is that of a quality... Read More →

Thursday February 7, 2019 09:15 - 10:15 CET
DIAlogue Space Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  Hot Topics/Stand Alone, Session
  • Featured Topics Value and Access
  • Tags Session